
Christopher W. Fulton
Examiner (ID: 16699, Phone: (571)272-2242 , Office: P/2855 )
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2859, 3641, 2406, 2899, 2841, 2855, 3108, 2856 |
| Total Applications | 3373 |
| Issued Applications | 2875 |
| Pending Applications | 85 |
| Abandoned Applications | 419 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5131570
[patent_doc_number] => 20070207967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'Peptide Inhibitors of Matrix Metalloproteinase Activity'
[patent_app_type] => utility
[patent_app_number] => 11/578793
[patent_app_country] => US
[patent_app_date] => 2005-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10473
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20070207967.pdf
[firstpage_image] =>[orig_patent_app_number] => 11578793
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/578793 | Peptide Inhibitors of Matrix Metalloproteinase Activity | Apr 20, 2005 | Abandoned |
Array
(
[id] => 6967083
[patent_doc_number] => 20050233980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'CGRP-antagonist in combination with a serotonin-reuptake inhibitor for the treatment of migraine'
[patent_app_type] => utility
[patent_app_number] => 11/108985
[patent_app_country] => US
[patent_app_date] => 2005-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5320
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20050233980.pdf
[firstpage_image] =>[orig_patent_app_number] => 11108985
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/108985 | CGRP-antagonist in combination with a serotonin-reuptake inhibitor for the treatment of migraine | Apr 18, 2005 | Abandoned |
Array
(
[id] => 4812772
[patent_doc_number] => 20080193403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Inducing And Maintaining Hair Color'
[patent_app_type] => utility
[patent_app_number] => 11/587594
[patent_app_country] => US
[patent_app_date] => 2005-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1838
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20080193403.pdf
[firstpage_image] =>[orig_patent_app_number] => 11587594
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/587594 | Inducing And Maintaining Hair Color | Apr 17, 2005 | Abandoned |
Array
(
[id] => 404695
[patent_doc_number] => 07288527
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-30
[patent_title] => 'Inhibition of allergic contact dermatitis by N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester'
[patent_app_type] => utility
[patent_app_number] => 11/106201
[patent_app_country] => US
[patent_app_date] => 2005-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5542
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/288/07288527.pdf
[firstpage_image] =>[orig_patent_app_number] => 11106201
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/106201 | Inhibition of allergic contact dermatitis by N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester | Apr 13, 2005 | Issued |
Array
(
[id] => 4833906
[patent_doc_number] => 20080132453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-05
[patent_title] => 'Neuromedin B and somatostatin receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 11/102981
[patent_app_country] => US
[patent_app_date] => 2005-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14838
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20080132453.pdf
[firstpage_image] =>[orig_patent_app_number] => 11102981
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/102981 | Neuromedin B and somatostatin receptor agonists | Apr 10, 2005 | Abandoned |
Array
(
[id] => 121700
[patent_doc_number] => 07709444
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-04
[patent_title] => 'Echinocandin pharmaceutical formulations containing micelle-forming surfactants'
[patent_app_type] => utility
[patent_app_number] => 11/103798
[patent_app_country] => US
[patent_app_date] => 2005-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11029
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/709/07709444.pdf
[firstpage_image] =>[orig_patent_app_number] => 11103798
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/103798 | Echinocandin pharmaceutical formulations containing micelle-forming surfactants | Apr 10, 2005 | Issued |
Array
(
[id] => 5441775
[patent_doc_number] => 20090093414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-09
[patent_title] => 'Hyaluronic Acid-Methotrexate Conjugate'
[patent_app_type] => utility
[patent_app_number] => 11/547158
[patent_app_country] => US
[patent_app_date] => 2005-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 25604
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20090093414.pdf
[firstpage_image] =>[orig_patent_app_number] => 11547158
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/547158 | Hyaluronic acid-methotrexate conjugate | Mar 31, 2005 | Issued |
Array
(
[id] => 7005746
[patent_doc_number] => 20050171059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Silanol enzyme inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/092316
[patent_app_country] => US
[patent_app_date] => 2005-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17124
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20050171059.pdf
[firstpage_image] =>[orig_patent_app_number] => 11092316
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/092316 | Silanol enzyme inhibitors | Mar 28, 2005 | Issued |
Array
(
[id] => 5259644
[patent_doc_number] => 20070213276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Epithelial Cell Growth Promoter'
[patent_app_type] => utility
[patent_app_number] => 10/594736
[patent_app_country] => US
[patent_app_date] => 2005-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7145
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20070213276.pdf
[firstpage_image] =>[orig_patent_app_number] => 10594736
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/594736 | Epithelial cell growth promoter | Mar 27, 2005 | Issued |
Array
(
[id] => 4740691
[patent_doc_number] => 20080234344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'Amino Acid and Peptide Conjugates of Arylalkylic Acids for Cosmetic Use'
[patent_app_type] => utility
[patent_app_number] => 10/593484
[patent_app_country] => US
[patent_app_date] => 2005-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10163
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20080234344.pdf
[firstpage_image] =>[orig_patent_app_number] => 10593484
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/593484 | Amino Acid and Peptide Conjugates of Arylalkylic Acids for Cosmetic Use | Mar 22, 2005 | Abandoned |
Array
(
[id] => 6967073
[patent_doc_number] => 20050233970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Methods for treating long QT syndrome'
[patent_app_type] => utility
[patent_app_number] => 11/088462
[patent_app_country] => US
[patent_app_date] => 2005-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4932
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20050233970.pdf
[firstpage_image] =>[orig_patent_app_number] => 11088462
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/088462 | Methods for treating long QT syndrome | Mar 22, 2005 | Abandoned |
Array
(
[id] => 7137922
[patent_doc_number] => 20050181987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'Compositions and methods for treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/081198
[patent_app_country] => US
[patent_app_date] => 2005-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18540
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20050181987.pdf
[firstpage_image] =>[orig_patent_app_number] => 11081198
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/081198 | Compositions and methods for treatment of cancer | Mar 15, 2005 | Abandoned |
Array
(
[id] => 7069065
[patent_doc_number] => 20050244448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Diagnosis and treatment of disorders of collagen and elastin metabolism'
[patent_app_type] => utility
[patent_app_number] => 11/082460
[patent_app_country] => US
[patent_app_date] => 2005-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 13060
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20050244448.pdf
[firstpage_image] =>[orig_patent_app_number] => 11082460
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/082460 | Diagnosis and treatment of disorders of collagen and elastin metabolism | Mar 15, 2005 | Abandoned |
Array
(
[id] => 418812
[patent_doc_number] => 07276484
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-02
[patent_title] => 'Dipeptide inhibitors of β-secretase'
[patent_app_type] => utility
[patent_app_number] => 11/075232
[patent_app_country] => US
[patent_app_date] => 2005-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22859
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/276/07276484.pdf
[firstpage_image] =>[orig_patent_app_number] => 11075232
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/075232 | Dipeptide inhibitors of β-secretase | Mar 7, 2005 | Issued |
Array
(
[id] => 5435012
[patent_doc_number] => 20090169598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'Treatment of bacterial infections'
[patent_app_type] => utility
[patent_app_number] => 10/586416
[patent_app_country] => US
[patent_app_date] => 2005-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18792
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20090169598.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586416
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586416 | Treatment of bacterial infections | Feb 27, 2005 | Issued |
Array
(
[id] => 285640
[patent_doc_number] => 07550567
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-23
[patent_title] => 'Fibrinogen purification'
[patent_app_type] => utility
[patent_app_number] => 11/062432
[patent_app_country] => US
[patent_app_date] => 2005-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 16054
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/550/07550567.pdf
[firstpage_image] =>[orig_patent_app_number] => 11062432
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/062432 | Fibrinogen purification | Feb 22, 2005 | Issued |
Array
(
[id] => 6960012
[patent_doc_number] => 20050215764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Biological polymer with differently charged portions'
[patent_app_type] => utility
[patent_app_number] => 11/060868
[patent_app_country] => US
[patent_app_date] => 2005-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 156730
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20050215764.pdf
[firstpage_image] =>[orig_patent_app_number] => 11060868
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/060868 | Biological polymer with differently charged portions | Feb 17, 2005 | Abandoned |
Array
(
[id] => 7005747
[patent_doc_number] => 20050171060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Phosphoramidates and methods therefor'
[patent_app_type] => utility
[patent_app_number] => 11/053024
[patent_app_country] => US
[patent_app_date] => 2005-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15188
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20050171060.pdf
[firstpage_image] =>[orig_patent_app_number] => 11053024
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/053024 | Phosphoramidates and methods therefor | Feb 7, 2005 | Issued |
Array
(
[id] => 798075
[patent_doc_number] => 07427662
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-23
[patent_title] => 'Inhibition of angiogenesis and destruction of angiogenic vessels by apolipoprotein A-I and high density lipoprotein'
[patent_app_type] => utility
[patent_app_number] => 11/047852
[patent_app_country] => US
[patent_app_date] => 2005-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5063
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/427/07427662.pdf
[firstpage_image] =>[orig_patent_app_number] => 11047852
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/047852 | Inhibition of angiogenesis and destruction of angiogenic vessels by apolipoprotein A-I and high density lipoprotein | Jan 31, 2005 | Issued |
Array
(
[id] => 13946
[patent_doc_number] => 07807781
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-05
[patent_title] => 'Inhibitors of serine protease activity and their use in methods and compositions for treatment of viral infections'
[patent_app_type] => utility
[patent_app_number] => 11/044224
[patent_app_country] => US
[patent_app_date] => 2005-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 17194
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/807/07807781.pdf
[firstpage_image] =>[orig_patent_app_number] => 11044224
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/044224 | Inhibitors of serine protease activity and their use in methods and compositions for treatment of viral infections | Jan 27, 2005 | Issued |